Peripheral Nerve Injury Clinical Trial
Official title:
Study of Surgical Methods for Repair of Clean Transections in Peripheral Nerve Injuries
Verified date | March 2008 |
Source | Isfahan University of Medical Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | Iran: Ministry of Health |
Study type | Interventional |
The purpose of this study is to determine which surgical approach is better for clean transection injury in peripheral nerves in outcomes.
Status | Completed |
Enrollment | 46 |
Est. completion date | December 2009 |
Est. primary completion date | December 2009 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - patients with confirmed clean transection injury between shoulder and wrist Exclusion Criteria: - crush injuries |
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Iran, Islamic Republic of | Al-zahra university hospital | Isfahan |
Lead Sponsor | Collaborator |
---|---|
Isfahan University of Medical Sciences |
Iran, Islamic Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | motor function | identification of motor level were done based on British Medical Research Council guided.The abductor pollicis brevis (APB) was used for the median nerve and the abductor digiti minimi (ADM) for the ulnar nerve. as follows: 0, M0, M1 and M2; 1, M3; 2, M4. | at 18 months post-operatively | Yes |
Secondary | sensory recovery | identification of motor and sensory level were done based on British Medical Research Council guided.The abductor pollicis brevis (APB) was used for the median nerve and the abductor digiti minimi (ADM) for the ulnar nerve. The results scored as follows: 0, S0, S1 and S2; 1, S3; 2, S4 and S5. | at 18 months post-operatively | Yes |
Secondary | nerve conduction velocity | For electrodiagnostic assessment, nerve conduction velocity (NCV) was tested as motor and sensory. The results categorized according to the Yale sensory scale and the severity of sensation and function of the nerves was scored as follows: 0, no sensation; 1, decreased or abnormal sensation; 2, normal sensation. | at 18 months post-operatively | Yes |
Secondary | electromyography | For an EMG, a needle electrode was inserted through the skin into the muscle which injured nerve supplied. The presence, size and shape of the waveform registered and the ability of the muscle to respond when the nerves were stimulated. Also these results scored as follows: 0, no activity; 1, few or single movement; 2, partial activity; 3, full activity. | at 18 months post-operatively | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02359825 -
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
|
Phase 1 | |
Not yet recruiting |
NCT02865317 -
Cortical Effects of Peripheral Nerve Injury At Birth
|
N/A | |
Recruiting |
NCT01554722 -
Needle Nerve Contact in Ultrasound Guided Femoral Block
|
N/A | |
Recruiting |
NCT06071988 -
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy
|
Phase 3 | |
Recruiting |
NCT06071936 -
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy
|
Phase 3 | |
Recruiting |
NCT05541250 -
Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI)
|
Phase 1 | |
Recruiting |
NCT06209632 -
Mirror Therapy Combined With Contralaterally Controlled Functional Electrical Stimulation for Peripheral Nerve Injury
|
N/A | |
Withdrawn |
NCT04270019 -
Polyethylene Glycol to Improve Sensation Following Digital Nerve Laceration
|
Phase 1/Phase 2 | |
Completed |
NCT01302275 -
Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain
|
Phase 4 | |
Terminated |
NCT01088256 -
Efficacy of Etoricoxib on Peripheral Hyperalgesia
|
Phase 2 | |
Completed |
NCT02228928 -
Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain
|
Phase 1/Phase 2 | |
Withdrawn |
NCT00950391 -
Enhancement of Functional Recovery After Peripheral Nerve Injury With Tacrolimus
|
Phase 1/Phase 2 | |
Completed |
NCT00953277 -
Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer
|
Phase 4 | |
Not yet recruiting |
NCT06003166 -
4-AP Peripheral Nerve Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT02666456 -
The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain
|
N/A | |
Not yet recruiting |
NCT02352649 -
Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Peripheral Nerve Injury
|
Phase 1/Phase 2 | |
Terminated |
NCT02034461 -
Micro-Electrodes Implanted in a Human Nerve
|
N/A | |
Completed |
NCT01596491 -
Study of Possible Changes in QST After Application of Capsaicin on Patients With Peripheral Neuropathic Pain
|
N/A | |
Recruiting |
NCT03147313 -
Extracorporal Shock Wave Treatment to Improve Nerve Regeneration
|
N/A |